ALPS Advisors’s Chimerix, Inc. CMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-105,711
Closed -$654K 990
2021
Q3
$654K Sell
105,711
-7,838
-7% -$53.9K 0.01% 467
2021
Q2
$908K Buy
113,549
+229
+0.2% +$1.9K 0.01% 411
2021
Q1
$1.09M Buy
113,320
+1,950
+2% +$17.9K 0.01% 387
2020
Q4
$538K Buy
+111,370
New +$404K 0.01% 484
2018
Q2
Sell
-63,099
Closed -$328K 972
2018
Q1
$328K Buy
63,099
+10,967
+21% +$55.6K ﹤0.01% 807
2017
Q4
$241K Buy
52,132
+5,801
+13% +$27.6K ﹤0.01% 779
2017
Q3
$243K Buy
46,331
+4,308
+10% +$21.2K ﹤0.01% 744
2017
Q2
$229K Buy
42,023
+2,178
+5% +$11.5K ﹤0.01% 742
2017
Q1
$254K Sell
39,845
-4,663
-10% -$26.4K ﹤0.01% 701
2016
Q4
$205K Sell
44,508
-14,406
-24% -$68K ﹤0.01% 696
2016
Q3
$326K Sell
58,914
-6,005
-9% -$27.5K ﹤0.01% 639
2016
Q2
$255K Buy
64,919
+13,023
+25% +$64.3K ﹤0.01% 589
2016
Q1
$265K Sell
51,896
-8,895
-15% -$58.1K ﹤0.01% 585
2015
Q4
$544K Sell
60,791
-11,317
-16% -$407K 0.01% 342
2015
Q3
$27.5K Buy
72,108
+27,422
+61% +$1.35M 0.03% 149
2015
Q2
$2.06M Buy
44,686
+24,987
+127% +$1M 0.02% 166
2015
Q1
$742K Buy
+19,699
New +$782K 0.01% 201

Other funds holding CMRX

ALPS Advisors's CMRX Position: Q4 2021 in Review

ALPS Advisors sold out of Chimerix, Inc. (CMRX) in Q4 2021, closing a stake of 105,711 shares — an estimated $654K sold.

ALPS Advisors first reported a position in CMRX in Q1 2015 and held it in 17 quarters. The position peaked at $2.06M in Q2 2015. 121 funds tracked by Wall St. Rank hold CMRX as of Q4 2021.

  • ALPS Advisors reported no remaining Chimerix, Inc. position as of Q4 2021 after selling out during the quarter.
  • ALPS Advisors sold 105,711 Chimerix, Inc. shares in Q4 2021, an estimated $654K.
  • ALPS Advisors first reported a position in Chimerix, Inc. in Q1 2015 and held it in 17 quarters.
  • ALPS Advisors's Chimerix, Inc. position peaked at $2.06M in Q2 2015.
  • 121 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q4 2021.

Based on ALPS Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.